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Background: Ischemic hypoxic brain injury often causes irreversible brain damage. The lack of effective and widely
applicable pharmacological treatments for ischemic stroke patients may explain a growing interest in traditional
medicines. From the point of view of “self-medication” or “preventive medicine,” Cordyceps sinensis was used in the
prevention of cerebral ischemia in this paper.
Methods: The right middle cerebral artery occlusion model was used in the study. The effects of Cordyceps sinensis
(Caterpillar fungus) extract on mortality rate, neurobehavior, grip strength, lactate dehydrogenase, glutathione
content, Lipid Peroxidation, glutathione peroxidase activity, glutathione reductase activity, catalase activity,
Na
+K
+ATPase activity and glutathione S transferase activity in a rat model were studied respectively.
Results: Cordyceps sinensis extract significantly improved the outcome in rats after cerebral ischemia and
reperfusion in terms of neurobehavioral function. At the same time, supplementation of Cordyceps sinensis extract
significantly boosted the defense mechanism against cerebral ischemia by increasing antioxidants activity related
to lesion pathogenesis. Restoration of the antioxidant homeostasis in the brain after reperfusion may have helped
the brain recover from ischemic injury.
Conclusions: These experimental results suggest that complement Cordyceps sinensis extract is protective after
cerebral ischemia in specific way. The administration of Cordyceps sinensis extract significantly reduced focal
cerebral ischemic/reperfusion injury. The defense mechanism against cerebral ischemia was by increasing
antioxidants activity related to lesion pathogenesis.
Background
Ischemic hypoxic brain injury often causes irreversible
brain damage. The cascade of events leading to neuronal
injury and death in ischemia includes the release of
cytokines and free radicals, and induction of inflamma-
tion, apoptosis, and excitotoxicity [1]. Reperfusion of
ischemic areas could exacerbate ischemic brain damage
through the generation of reactive oxygen species. The
lack of effective and widely applicable pharmacological
treatments for ischemic stroke patients may explain a
growing interest in traditional medicines. Recently, from
the point of view of “self-medication” or “preventive
medicine,” several dietary supplements are used in the
prevention of life-style related diseases including cere-
bral ischemia.
Mushrooms and primarily basidiomycetous fungi are
popular and valuable foods that are low in calories and
high in minerals, essential amino acids, vitamins, and
fibers [2]. Some of them produce substances with poten-
tial medical effects, and are called medicinal mushrooms
[3]. Cordyceps sinensis (Caterpillar fungus) (CS) has
been used as a tonic for longevity, endurance, and vital-
ity for thousands of years by the Chinese [4]. Many stu-
dies have shown that Cordyceps sinensis (CS) modulates
immune responses [5-7], inhibits tumor cell proliferation
[8,9], enhances hepatic function [10], regulates insulin
sensitivity [11], decreases plasma cholesterol levels [12],
and has hypotensive and vasorelaxant activity [13]. In
particular, CS modulates steroidogenesis. Huang
reported that CS induced 17b-estradiol production [14].
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treatment has both potent and long-lasting effects on
improved pathophysiological outcome after brain ische-
mia in experimental animal models [15,16]. Clinical stu-
dies have demonstrated that estrogens enhance mood
and cognition and delay cognitive decline [17,18]. Thus,
we hypothesize that Cordyceps sinensis possess protec-
tive effect of against ischemia-induced brain infarction
by modulating 17b-estradiol production. The present
study investigated the effects of Cordyceps sinensis on
mortality rate, neurobehavior, grip strength, lactate
dehydrogenase, glutathione content, Lipid Peroxidation,
glutathione peroxidase activity, glutathione reductase
activity, catalase activity, Na
+K
+ATPase activity and glu-
tathione S transferase activity in a rat model. These data
may help in the development of effective and widely
applicable pharmacological treatments for ischemic
stroke patients with traditional medicines.
Materials and methods
Animals
Healthy male adult wistar rats (2 months old and weigh-
ing 225 ± 25 g) were used in the study. This study was
performed in accordance with the Guide for the Care
and Use of Laboratory Animals. Care was taken to mini-
mize discomfort, distress, and pain to the animals.
Chemicals
Cordyceps sinensis extract (CSE) preparation
The seed of Cordyceps sinensis was purchased from the
Agricultural Culture Collection of China. Five to six
pieces of the mycelia of Cordyceps sinensis were trans-
ferred from a slant into 500 mL Erlenmeyer flasks con-
taining 300 mL of fermented culture medium (20%
potato extract liquid +2.0% dextrose +0.1% KH2PO4+
0.05% MgSO4). The culture was incubated at 27°C on a
rotary shaker at 180 rmp for 7 days [19,20].
Preparation of the CSE was as follows: 30 g of cul-
tured Cordyceps sinensis mycelium powder was
extracted with 240 ml of water in a water bath of 100°C
for 3 h with reflux. Eighty milliliters of the water extract
was then lyophilized to yield 2.9 g of the dry powder.
The rest of the water extract (160 ml) was mixed with
160 ml of absolute ethanol for extraction. This 50%
alcoholic fraction was dried to yield 3.7 g of the dry
powder. The combination of both aqueous and alcohol
extracts was then used in the present study.
Experimental design
The animals were separated into three groups of eight
rats each. The first group served as sham (SHAM). The
second group was the ischemic group (MCAO). Group I
and group II were treated orally by distilled water for 30
days respectively. Group III (CSE-4), Group IV (CSE-8)
and Group V (CSE-10) were treated orally by CSE (4, 8
and 10 mg/kg/day respectively) for 30 days followed by
MCAO induced cerebral ischemia.
The right middle cerebral artery occlusion (MCAO)
was performed using an intraluminal filament model
and the method described by Longa et al.[ 2 1 ] .I nb r i e f ,
the rats were anesthetized with chloral hydrate (400 mg/
kg, i.p.), a 4-0 nylon monofilament with a blunt end was
introduced into the external carotid artery (ECA) and
advanced into the middle cerebral artery via the internal
carotid artery (ICA) (17-20 mm), until a slight resistance
was felt. Successful occlusion was confirmed by an
87-90% reduction in cerebral blood flow (CBF), as mea-
sured by laser-Doppler flowmetry [22].
Two hours after the induction of ischemia, the fila-
ment was slowly withdrawn and the animals were
returned to their cages for a period of 22 hours of
reperfusion. Throughout the procedure, the body tem-
perature was maintained at 37
° C, with a thermostati-
cally controlled infrared lamp. In sham rats, the ECA
was surgically prepared for the insertion of the filament,
but the filament was not inserted. The final number of
r a t sw a sa sf o l l o w s :S H A Mg r o u pn=8 ;M C A Og r o u p
Figure 1 Effect of CSE on the Development of Behavioral
Abnormalities after middle cerebral artery occlusion. Values are
shown as means ± SEM. *p < 0.05 vs. MCAO group, **p < 0.01 vs.
MCAO group. (FSHAM = 17.642, dfSHAM = 11, pSHAM = 0.001, F CSE-4 =
2.252, df CSE-4 = 11, p CSE-4 = 0.162, F CSE-8 = 16.396, df CSE-8 = 11,
p CSE-8 = 0.01, F CSE-10 = 22.738, dfSHAM = 11, pSHAM = 0.02).
Table 1 Effect of CSE on basal grip strength
Different groups Grip strength
(Kg Units)
F-values df-values p-values
MCAO group 0.598 ± 0.004
b
SHAM group 0.963 ± 0.006
a 0.158 11 0.001
CSE-4 group 0.663 ± 0.022
b 0.158 11 0.445
CSE-8 group 0.978 ± 0.005
a 0.146 11 0.001
CSE-10 group 0.890 ± 0.013
a 2.964 11 0.005
Values are shown as means ± SEM. The different letters in the same column
indicate a statistical difference (p < 0.01 vs. MCAO group).
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Neurobehavioral test
The sensorimotor integrity was conducted to assess the
neurobehavior at 24 h after MCAO in rats [23]. Five
categories of motor neurological findings were scored: 0,
no observable deficit; 1, forelimb flexion; 2, forelimb
flexion and decreased resistance to lateral push; 3, fore-
limb flexion, decreased resistance to lateral push and
unilateral circling; 4, forelimb flexion, unable or difficult
to ambulate. Animals that showed the features of the
higher scores also showed all the features of the lower
grades.
Grip strength study
Grip strength in all the animals was measured for eva-
luation of neuromuscular strength, as described by Ali
et al. [24]. The neuromuscular strength tests were car-
ried out between 9:00 a.m. to 4:00 p.m. under standard
laboratory conditions.
Tissue preparation
After grip strength measurement, blood samples were
drawn from the tail vein from all the groups and
serum was separated for biochemical estimations.
Thereafter, the animals were sacrificed immediately
and their brains were taken out to dissect the hippo-
campus (HIP). Post-mitochondrial supernatant (PMS)
obtained from 10% homogenate of tissue was used for
the estimation of various parameters related with oxi-
dative stress.
Biochemical estimations
In serum, lactate dehydrogenase (LDH) was estimated
using a method described by Lum et al [25]. The PMS
and HIP were used for the assay of glutathione (GSH)
content, Lipid peroxidation (LPO), glutathione peroxi-
dase (GPx) activity, glutathione reductase (GR) activity,
catalase (CAT) activity, Na
+K
+ATPase activity and glu-
tathione S transferase (GST) activity [26-31].
Statistical analysis
The data are expressed as mean ± SEM. Statistical dif-
ferences between means were determined by one-way
analysis of variance (ANOVA), followed by Dunnett t-
test. The values of P < 0.05 were considered as
significant.
Results and discussion
In this study, the cerebroprotective effect of Cordyceps
sinensis extract on ischemic neuronal damage was
clearly demonstrated using focal ischemia model rats.
The behavioral tasks adopted in this study were
designed to assess impairments consistent with the
known functional architecture of the rat brain.
Twenty-four hours after MCAO in rats, neurological
deficit scores were significantly reduced in CSE-8 -trea-
ted rats and CSE-10 -treated rats. The neurobehavior
for the SHAM group was 0.9 (0.6–1.1), the MCAO
group was 3.7 (2.6–5.3), the CSE-4 group was 2.2 (1.8–
4.1), the CSE-8 group was 1.2 (0.8–4.1) and the CSE-10
group was 1.5 (1.0–4.1). It is clear that the behavioral
abnormality was significantly developed in the MCAO
group as compared with the sham (Figure 1). In con-
trast, the CSE-8 group and CSE-10 significantly sup-
pressed the development of behavioral abnormality as
compared with the MCAO group (Figure 1).
The grip strength in the SHAM group was found to
be 0.963 ± 0.006 kg units. A significant decrease in the
grip strength was observed in the MCAO group, as
compared to the sham rats (P < 0.01). CSE-8 and CSE-
10 treated rats showed a significant increase in grip
strength, as compared to the MCAO group (P < 0.01)
(Table 1).
Table 2 Effect of CSE on serum LDH levels
Different groups LDH (IU/L) F-values df-values p-values
MCAO group 170.201 ± 3.741
SHAM group 86.322 ± 2.663*** 6.556 5.183 0.000
CSE-4 group 156.601 ± 2.221 7.199 11 0.118
CSE-8 group 106.632 ± 3.111** 7.497 5.063 0.001
CSE-10 group 131.232 ± 2.101** 0.426 11 0.005
Values are shown as means ± SEM. **p < 0.01 vs. MCAO group, ***p < 0.001
vs. MCAO group
Table 3 Effect of CSE on Hippocampus GSH
Different groups Hippocampus GSH (nmol GSH/mg protein) F-values df-values p-values
MCAO group 0.763 ± 0.025
SHAM group 2.298 ± 0.013** 7.992 6.285 0.009
CSE-4 group 1.015 ± 0.015 1.863 11 0.379
CSE-8 group 2.465 ± 0.055** 6.537 6.406 0.008
CSE-10 group 1.233 ± 0.022* 2.964 11 0.025
Values are shown as means ± SEM. *p < 0.05 vs. MCAO group, **p < 0.01 vs. MCAO group
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fusion occurs due to oxidative stress that may potentiate
ischemic injury [32]. Lactate dehydrogenase was mea-
sured to evaluate the role of antioxidative stress in the
protection of CSE. The serum LDH levels in SHAM
group were found to be 86.322 ± 2.663 IU/L. A signifi-
cant increase in the activity of LDH in serum was
observed in MCAO group, as compared to the SHAM
group; whereas, CSE-8 and CSE-10 treatment signifi-
cantly resulted in decreased serum LDH levels when
compared with MCAO group rats (Table 2).
Reduced glutathione (GSH) is one of the primary
endogenous antioxidant defense systems in the brain,
which removes hydrogen peroxide and lipid peroxides.
Decline in GSH levels could either increase or reflect
oxidative status [33,34]. Concentrations of GSH were
lower in MCAO group than those in SHAM group
(Table 3 and Table 4). CSE-8 produced the increase in
the level of GSH significantly. The same results did
occur in the CSE-10 group.
It can be attributed to several factors such as cleavage
GSH to cysteine, decrease in the synthesis of GSH and
the formation of mixed disulfides, causing their cellular
stores to be depleted [35].
The large numbers of polyunsaturated fatty acids
make cell membranes particularly vulnerable to lipid
peroxidation. The oxidation of polyunsaturated fatty
acids alters the structure of the membrane with resul-
tant changes in fluidity and permeability. Lipid peroxi-
dation can also inhibit the function of membrane bound
receptors and enzymes [36]. The level of LPO content
adds to the proof of the increased peroxidative damage
during cerebral ischemia. A significant increase in the
content of LPO was observed in the MCAO group
when compared with the SHAM group. In the CSE-8
and CSE-10 group, a significant decrease was seen in
the level of LPO when compared with the MCAO
group (Table 5).
It has been proposed that antioxidant changes reflect
an altered redox balance in several pathological states.
The antioxidants would be consumed in the reaction
with free radicals. Therefore, the measurement of endo-
genous antioxidants enzymes i.e. GPx, GR, CAT and
G S Ta sw e l la sN a
+K
+ATPase has been performed to
estimate the amount of oxidative stress. Activities of
various antioxidant enzymes and Na
+K
+ATPase of dif-
ferent groups have been listed in Table 6, Table 7,
Table 8, Table 9 and Table 10. The activity of endogen-
ous antioxidant enzymes was decreased significantly in
the MCAO group, as compared to the sham group,
whereas in the CSE-8 group, CSE-treatment showed a
significant restoration in the level of various enzymes as
compared with MCAO group .T h es a m er e s u l t sd i d
occur in the CSE-10 group.
A great deal of effort has been directed toward search-
ing for a new drug that can be used for protection of
cerebral ischemia-reperfusion injury. From the point of
view of “self-medication” or “preventive medicine,” Cor-
dyceps sinensis was used in the prevention of cerebral
ischemia in this paper. Although Cordyceps sinensis is
extensively used in Chinese medicine, it lacks scientific
grounds for its efficacy and to the best of our knowledge
this is the first study to report its possible protective
mechanisms against cerebral ischemic damage.
Here we showed that the Cordyceps sinensis extract
significantly improved the outcome in rats after cerebral
ischemia and reperfusion in terms of neurobehavioral
Table 4 Effect of CSE on Cerebral cortex GSH
Different groups Cerebral cortex GSH (nmol GSH/mg protein) F-values df-values p-values
MCAO group 1.012 ± 0.010
SHAM group 1.803 ± 0.026* 4.193 11 0.017
CSE-4 group 1.095 ± 0.021 4.043 11 0.336
CSE-8 group 1.495 ± 0.053* 3.306 11 0.026
CSE-10 group 1.295 ± 0.011* 3.418 11 0.427
Values are shown as means ± SEM. *p < 0.05 vs. MCAO group.






MCAO group 20.21 ± 1.41
SHAM group 13.23 ± 0.66** 5.254 6.996 0.003
CSE-4 group 20.01 ± 0.21 19.460 5.010 0.846
CSE-8 group 15.32 ± 0.11* 1.304 10 0.043
CSE-10 group 15.22 ± 0.21* 1.305 10 0.042
Values are shown as means ± SEM. *p < 0.05 vs. MCAO group, **p < 0.01 vs.
MCAO group.
Table 6 Effect of CSE on the activity of GPx
Different groups GPx F-values df-values p-values
MCAO 8.01 ± 0.42
SHAM 15.98 ± 1.23** 0.714 11 0.001
CSE-4 9.10 ± 1.02 0.911 11 0.306
CSE-8 12.16 ± 1.32** 3.557 11 0.006
CSE-10 10.10 ± 1.11* 0.052 11 0.04
Values are shown as means ± SEM. *p < 0.05 vs. MCAO group, **p < 0.01 vs.
MCAO group.
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ceps sinensis extract significantly boosted the defense
mechanism against cerebral ischemia by increasing anti-
oxidants activity related to lesion pathogenesis. Restora-
tion of the antioxidant homeostasis in the brain after
reperfusion may have helped the brain recover from
ischemic injury.
Conclusions
These experimental results suggest that complement
Cordyceps sinensis extract is protective after cerebral
ischemia in specific way. The administration of CSE
significantly reduced focal cerebral ischemic/reperfusion
injury. The defense mechanism against cerebral ischemia
was by increasing antioxidants activity related to lesion
pathogenesis.
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